Adverse drug events (ADEs) in PharmaNet - Government of British Columbia
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
This article is an excerpt. To read the full content, visit the original source. Government of British Columbia
Related articles

Community health practice access to PharmaNet - Government of British Columbia
For explanation of roles (signing authority, privacy officer, etc.), refer to Site roles. 1. Private community health practice site registration for PharmaNet access: landing page

Advocates call for action on adverse health effects from digital media - Global News
Health Matters: 8 Ebola cases confirmed in Kenya Pope Leo’s XIV cancer diagnosis highlights crucial need for lung heath awareness, thoracic surgeon weighs in

Number of adverse reactions by plasma donors reduced after Grifols flagged misclassification: Health Canada - CBC
ManitobaNumerous incidents in which people were purportedly left with some serious medical condition after donating plasma at clinics owned by Grifols had actually been "misclassified" by the company, Health Canada says. List of serious medical events reported by clinics owned by company went from 25 to 6 after reviewArturo Chang · CBC News · Posted: Aug 19, 2026 6:23 PM EDT | Last Updated: August 19Listen to this articleEstimated 6 minutesThe audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. More than a dozen incidents involving donors at facilities currently owned by Grifols were misclassified by the company, Health Canada says. (CBC News)Numerous incidents in which people were purportedly left with some serious medical condition after donating plasma at clinics owned by Grifols had actually been "misclassified" by the company, Health Canada says. The number of serious adverse reactions reported by plasma clinics in Canada has been revised after a "verification exercise," the federal department said.
0 comments
No comments yet. Be the first to share your thoughts!